SERTAD2 and ovarian carcinoma: For example, a clinical investigation by Martini et al. revealed that patients with stage I epithelial ovarian cancer can be clearly stratified into low- and high-risk individuals using the expression profile lncRNAs including PVT1, SERTAD2-3, and miR-200c-3p simultaneously [39].